Beranda › HIV › Texas › Houston
Uji klinis HIV di Houston, TX
17 studi untuk HIV mencari peserta di lokasi sekitar Houston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
Menerima pesertaStudi observasional
- UT Health, Houston
- Thomas Street at Quentin Mease Health Center, Houston
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
Menerima pesertaFase 3
- GSK Investigational Site, Houston
ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV
Menerima peserta
- Baylor College of Medicine, Houston
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Menerima pesertaFase 2/3
- Saint Hope Foundation, Inc. ( Site 1504), Bellaire · 7 mi jauhnya
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Menerima pesertaFase 1/2
- 5128, Baylor College of Medicine/Texas Children's Hospital Clinical Research Site, Houston
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
Menerima pesertaFase 2
- M D Anderson Cancer Center, Houston
A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV
Menerima pesertaFase 1Sukarelawan sehat diterima
- The Crofoot Research Center, Houston
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
Menerima peserta
- University of Texas M.D. Anderson Cancer Center, Houston
Positive Peers Intervention Clinical Trial
Menerima peserta
- Thomas Street Clinic, Houston
Screen2Prevent (S2P)
Menerima pesertaSukarelawan sehat diterima
- Baylor College of Medicine, Houston
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
Menerima pesertaFase 2
- UT Health Houston, Houston
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Menerima pesertaFase 2
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
- GSK Investigational Site, Bellaire · 7 mi jauhnya
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
Menerima peserta
- Houston Methodist Research Institute, Houston
Menopausal HT for Women Living With HIV (HoT)
Menerima pesertaFase 4
- Houston AIDS Research Team CRS (31473), Houston
Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness
Menerima peserta
- The University of Texas Health Science Center at Houston, Houston
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
Menerima pesertaFase 2
- UT Health Houston, Houston
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
Menerima pesertaFase 1/2
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
Uji klinis HIV di kota lain
- Washington, DC22 studi
- New York City, NY19 studi
- Miami, FL17 studi
- Baltimore, MD16 studi
- San Francisco, CA15 studi
- Atlanta, GA14 studi
- Chicago, IL14 studi
- Boston, MA11 studi
- Philadelphia, PA11 studi
- San Diego, CA10 studi
- Los Angeles, CA9 studi
- Seattle, WA8 studi
Studi lain di Houston
- Kanker Paru Non-Sel Kecil145 studi
- Kanker Payudara126 studi
- Kanker (semua jenis)121 studi
- Kanker Metastatik104 studi
- Kanker Kolorektal102 studi
- Kanker Ovarium89 studi
- Leukemia Mieloid Akut85 studi
- Kanker Paru78 studi
- Kanker Prostat76 studi
- Kanker Endometrium68 studi
- Kanker Pankreas61 studi
- Melanoma59 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.